Tempest Therapeutics adjourns special meeting and reconvenes it for December 11
At the November 12, 2026 reconvened special meeting, Tempest Therapeutics said there were insufficient votes to approve a proposal to amend its certificate of incorporation, and the meeting was adjourned again. Shares present virtually or represented by proxy totaled 11,052,422, or 74.64% of the 14,806,997 shares outstanding as of the May 28, 2026 record date, constituting a quorum. The meeting will reconvene on December 11, 2026 at 12:00 p.m. Eastern Time via live webcast to vote on the unchanged proposal, whic...
Key takeaways
Meeting status: The special meeting was reconvened and adjourned on November 12, 2026 because there were insufficient votes to approve the proposal.
Meeting history: The meeting was originally convened on July 27, 2026 and previously reconvened and adjourned on August 17, September 15 and October 14, 2026.
Proposal: Stockholders are voting on a certificate of amendment intended to replace specified supermajority voting requirements and permit stockholder action by written consent.
Quorum: 11,052,422 shares, or 74.64% of the 14,806,997 shares outstanding as of the May 28, 2026 record date, were present virtually or represented by proxy.
Vote threshold: The proposal requires the affirmative vote of holders of at least 75% of the votes all stockholders would be entitled to cast in an annual election of directors or class of directors.
Reconvening: The meeting will reconvene December 11, 2026 at 12:00 p.m. Eastern Time via live webcast at www.virtualshareholdermeeting.com/TPST2026SM2, using the same access code as the July 27 meeting.
Unchanged terms: The proposal and May 28, 2026 record date remain unchanged; previously submitted proxies will be voted unless revoked, and stockholders who already voted need not take any action to retain their vote.
Key metrics
Primary source
TickerStar generated this brief from an official company, investor-relations, earnings-call, or regulatory source. Review the primary material before making an investment decision.
Open SEC filingFollow TPST in real time
Get material earnings, filing, IR, and earnings-call alerts by email.